• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
CommentaryHealth

Medical malpractice payouts are ballooning—and insurers are warning it will cost patients

By
Robert White
Robert White
Down Arrow Button Icon
By
Robert White
Robert White
Down Arrow Button Icon
July 2, 2024, 7:21 AM ET
Robert White is the president of The Doctors Company, America's largest physician-owned medical malpractice insurer.
Jurys are awarding ever-larger damages in medical malpractice cases.
Jurys are awarding ever-larger damages in medical malpractice cases.Getty Images

From 2013 to 2023, the American court system saw a roughly 67% increase in the number of medical malpractice verdicts awarding $10 million or more. Last year, more than half of these verdicts awarded $25 million or more in damages to patients. The average of the top 50 MPL verdicts increased 50% in 2023 to $48 million each from $32 million each in 2022.

Skyrocketing dollar amounts could give an observer the idea that the pace of medical malpractice litigation is up—yet the opposite is true. Claim frequency is flat or decreasing nationwide.

In the insurance industry, we call this “social inflation.” The term describes periods like this one, in which the costs of medical malpractice claim resolution are increasing faster than general inflation. Social inflation arises from the convergence of various social and economic forces: desensitization to big numbers, third-party investors in litigation, and more.

Social inflation increases the price of healthcare. It ratchets up the costs of doing business for healthcare professionals and organizations, and fear of litigation inspires defensive medicine.

Fortunately, through tort reform, states may be able to contain social inflation’s effects on healthcare costs.

Numbness to big numbers

Our society has become inured to large quantities and large dollar amounts. Professional athletes routinely chalk up tens of millions of dollars per year, and we’ve seen lottery jackpots of over a billion. Most people shrug at a multimillion-dollar verdict.

For decades, researchers in cognition have observed that their fellow citizens experience “number numbness.” We human beings are generally bad at understanding large numbers, and numbers over one million are especially hard to grasp.

Researchers who study risk and decision-making say that some of us are more prone than others to being swayed by moods and narratives, especially in an environment of heightened emotion—and heightened emotion is definitely present in a court proceeding surrounding an allegation of medical malpractice. Whether or not a medical error has occurred, adverse events can happen to patients, and the results are often devastating.

We know that within a cultural setting of number numbness, the courtroom’s environment of strong emotion can further skew our understanding of large numbers. Amplifying this effect, plaintiffs’ attorneys attempt to exploit jurors’ emotions using “reptile theory”: They frame the defendant as threatening, which arouses jurors’ primal sense of fear—thus engaging the more basic parts of the human brain, those responsible for fight-or-flight responses.

The end results are verdicts designed to punish the defendant to deter others. These verdicts go far beyond making the injured party whole. Exploiting jurors’ sense of empathy to achieve high-dollar verdicts might even lead to harming the very people jurors wish to help: patients.

Large verdicts pay attorneys—and investors

Although juries that award large sums to plaintiffs may feel concern for an injured person, up to 40% of that indemnity can go to the plaintiff’s attorney, not the plaintiff.

Further, most Americans are unaware that people invest in medical malpractice lawsuits, but hedge funds and other investors often float plaintiffs’ attorneys’ litigation in exchange for a share of the settlement or jury award. Enriching these third-party funders is probably not what jurors have in mind when they choose massive awards.

Large verdicts promote defensive medicine

Defensive medicine involves adding steps to the course of care out of fear of litigation, rather than hope for a treatment outcome. For instance, many of us are familiar with the idea that doctors may seek to protect themselves by ordering medically unnecessary tests. This increases the cost of healthcare overall.

The exact amount of spending increase is unknown, but some estimate that defensive medicine adds at least $55 billion per year to U.S. healthcare costs. Tort reform measures, including caps on noneconomic damages, can help mitigate these fears and added costs.

The ripple effects spread far beyond the parties to a medical malpractice lawsuit. Eventually, premiums for medical professionals are affected, and increases in premiums for healthcare professionals can affect the cost of care.

And it’s not only healthcare that has to pay the “tort tax.” In 2022, the U.S. Chamber of Commerce Institute for Legal Reform calculated a tort cost equivalent to 2.1% of gross domestic product, or $3,621 per American household.

Steering U.S. healthcare through the challenges ahead

The insurance industry needs our elected representatives to support damage caps and other tort reform measures.

A survey conducted by the American Property Casualty Insurance Association and Munich Reinsurance America indicates that many Americans are not aware of litigation aspects such as third-party litigation funding or the potential impact on their own household costs—but upon learning about these issues, most people surveyed wanted commonsense reforms.

American healthcare has plenty of challenges to navigate—halting social inflation won’t overcome them all. But it will be easier for U.S. healthcare to steer through those obstacles if it is piloted by clinicians who are free from fears of crippling litigation costs.

Join us at the Fortune Workplace Innovation Summit May 19–20, 2026, in Atlanta. The next era of workplace innovation is here—and the old playbook is being rewritten. At this exclusive, high-energy event, the world’s most innovative leaders will convene to explore how AI, humanity, and strategy converge to redefine, again, the future of work. Register now.
About the Author
By Robert White
See full bioRight Arrow Button Icon

Latest in Commentary

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Commentary

dog
CommentaryAnimals
You love your dog too much. Blame the broken American Dream and loss of purpose since the pandemic
By Margret Grebowicz and The ConversationFebruary 13, 2026
21 hours ago
julio
CommentaryLeadership
Why choosing not to hire was the solution for my startup — we raised over $100 million and tripled revenue with the same people
By Julio MartínezFebruary 13, 2026
1 day ago
betsy atkins
CommentaryCorporate Governance
Why PayPal’s board chose to act early—and what other boards can learn
By Betsy AtkinsFebruary 12, 2026
2 days ago
sid
CommentaryOil
Forget ‘peak oil’: the era of scarcity is dead, and now we’re drowning in abundance
By Siddharth MisraFebruary 12, 2026
2 days ago
TrumpRx
CommentaryPharmaceutical Industry
TrumpRx is here and it helps, though a bit less than advertised
By Jeffrey Sonnenfeld, Stephen Henriques, Ferron Chen, Asuka Koda and Vanessa McLennanFebruary 11, 2026
3 days ago
saunders
CommentaryLeadership
Bausch + Lomb CEO: Standing still is the new falling behind
By Brent SaundersFebruary 11, 2026
3 days ago

Most Popular

placeholder alt text
Economy
Some folks on Wall Street think yesterday’s U.S. jobs number is ‘implausible’ and thus due for a downward correction
By Jim EdwardsFebruary 12, 2026
2 days ago
placeholder alt text
North America
‘I gave another girl to Kimbal’: Inside Jeffrey Epstein’s honey-trap plan targeting Elon Musk through his brother
By Eva Roytburg and Jessica MathewsFebruary 13, 2026
19 hours ago
placeholder alt text
Success
Actress Jennifer Garner just took her $724 million organic food empire public. She started her career making just $150 weekly as a ‘broke’ understudy
By Emma BurleighFebruary 13, 2026
19 hours ago
placeholder alt text
Commentary
Something big is happening in AI — and most people will be blindsided
By Matt ShumerFebruary 11, 2026
3 days ago
placeholder alt text
Economy
‘Nothing short of self-sabotage’: Watchdog warns about national debt setting new record in just 4 years
By Tristan BoveFebruary 11, 2026
3 days ago
placeholder alt text
AI
Microsoft AI chief gives it 18 months—for all white-collar work to be automated by AI
By Jake AngeloFebruary 13, 2026
17 hours ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.